A. Chondrosarcoma

B. Osteoma

C. None of the above

A. Aplastic anemia

B. Viral infection

D. Typhoid fever

A. Diminished generation of adenosine triphosphate (ATP)

B. Detachment of ribosomes from the granular endoplasmic reticulum

D. Formation of blebs in the plasma membrane

A. Induces cell mediated immunity

B. None of the above

D. Induces immunity by activation of cytoxic T-cells

A. Increased vascular permeability

B. Stasis of blood

C. Vasodilation

A. Kidney

C. Liver

D. Lung

B. Kidneys

C. Heart

D. Intestines

B. Hamartoma

C. Plemorphic tumours

D. Choristoma

A. Atelexis

B. Achalasia

D. Cacoguesia

A. petechiae small pin point hemorrhages

B. Ecchymosis large extravasation of blood in to the skin and mucous membrane

C. Purpura small areas (1cm) of hemorrhage in to the skin and mucous membrane

B. 20 to 30% haemoglobins

C. 10 to 20% haemoglobins

D. 50 to 60% haemoglobins

A. Systemic manifestations

C. Reed Sternberg cells

D. Occurence in young adults

A. Intestine

B. Ovary

D. Lung

A. Cicatrisation

B. Secondary intention

C. All of the above

A. None

B. Karyorhexis

C. Pyknosis

A. Turner syndrome

B. Down syndrome

D. Marfan syndrome

A. Kupffer cells in liver

B. Histiocytes in connective tissues

D. Microglial cells in nervous system

A. Peripheral vasodilation

C. Increased vascular permeability

D. Endothelial injury

A. It has fibrin precipitates

B. It is associated with many types of severe inflammation

D. It induces connective tissue organization

A. Type II hyp

C. Type IV hyp

D. Type III hyp

A. Macrophages

B. Dendritic cells

C. Langerhans cells

B. Hyper chromatic and pleomorphism of tumour cells

C. All of the above

D. Neoplastic cells are cohesive

A. Klutischky cells

B. Brush cells

C. Clara cells

A. Sickle cell anaemia

B. Albinism

C. Icthyosis

A. All of the above

B. Papilloma

C. Sarcomas

A. G2 phase

B. M phase

C. S phase

B. Chemicals

C. Viruses

D. Radiation

A. None of the above

B. A transplant immunity

C. An anaphylactic shock

A. Fatty streak

B. Hypercoagulability

C. Alteration in blood flow

A. Glucose-6 phosphate dehydrogenase deficiency

B. Sickle cell trait

D. a-Thalassamia

B. Cells containing excessive melanin pigment

C. Melangocytes which are functionally more active

D. large melanocytes

A. TNM and AJC systems can be used for staging malignant tumours

B. Staging is the extent of spread of tumour

C. Grading is the degree of macroscopic and microscopic differentiation of tumour

A. Cloudy appearance

C. Increased specific gravity

D. High protein

B. Increased osmotic pressure

C. Increased albumin in blood and decreased globin

D. None of the above

A. Hypoparathyroidism

B. Vitamin D deficiency

C. All of the above

A. Factor VIII

B. Factor X

D. Factor V

A. Arsenic

C. Lead

D. Mercury

A. Myxoedema

C. Dependent edema

D. Pitting edema

A. Tuberculous lesions

B. Atherosclerotic lesions

C. Occurs in damaged tissue

A. Trotters syndrome

B. Vincent stomatitis

C. None of the above

A. Giant cells

B. Plasma cells

D. Eosinophilis

B. Chronic monocytic leukemia

C. Chronic lymphoblastic leukemia

D. Chronic myeloid leukemia

A. G1 to S phase of cell cycle

B. Blood coagulation

D. Mitotic cell division

A. Haemophilia A

B. Sickle cell anaemia

D. Fetal alcohol syndrome

A. Sarcoidosis

B. Leprosy

D. Midline lethal granuloma

A. Characteristic of focal bacterial infections

B. Characteristic by loss of tissue architecture

D. None of the above

A. Vasospasm

B. Peripheral neuritis

D. None of the above

A. Iron deficiency anemia

B. Idiopathic thrombocytopenic purpura

D. Thalassemia

B. Massons toichrome

C. Reticulin

D. Vonkosa

A. Whole blood

B. cryoprecipitate

D. dried freeze plasma